Competition
Competitive Bottom Line
Marex has a real but narrow moat: a four-engine non-bank balance sheet (clearing, agency, market-making, structured solutions) that is hard to assemble, regulator-gated, and harder to copy than to compete with. The evidence is in the numbers — 27.5% FY2025 ROE rising to 37.4% in Q1 2026, 95%+ client revenue retention, top-50 client revenue +80% YoY, and a +27% FY2025 consolidated revenue print despite the 33% NII headwind. It is not a wide moat: the FY2025 competitive map shifted twice in 12 months — StoneX bought R.J. O'Brien (July 2025) and is now the largest non-bank FCM in the US, displacing Marex's prior positioning claim, and BGC bought OTC Global (April 2025), calling itself the "world's largest energy, commodities, and shipping broker by revenue" and naming Marex Group PLC by name as an ECS competitor in its 10-K. The single peer that matters most is StoneX — same shape, just doubled in scale.
One-line read: Marex earns above its weight class today (highest ROE in the cohort, lowest comp ratio for what it does), but the cohort consolidated faster than Marex did in FY2025. The next 18 months are the test of whether share gain accelerates or whether SNEX and BGC absorb the platform-broker premium that Marex IPO'd into.
The Right Peer Set
There is no single like-for-like comp because Marex assembles four service lines on one balance sheet. The five peers below each occupy a different corner of that box — together they span the economic decisions an investor needs to underwrite: scale, voice vs. electronic, capital intensity, asset-class breadth, pure-principal vs. agency.
Native currency basis: SNEX/IBKR/BGC/MRX in USD; TCAP in GBP; FLOW in EUR. Market cap and enterprise value as of 2026-05-04/06 (Yahoo Finance / company filings via competition staging). Marex enterprise value is not informative — client cash float (~$18bn average balances) makes EV negative, which is true for every clearing FCM and is why EV/revenue is omitted from the valuation lens. TP ICAP and Flow Traders FY2025 revenue shown in native currency (£2,351M and €480M respectively); their dollar equivalents (~$3.2bn and ~$565M) appear in the Industry tab.
The two peers Marex would be expected to beat (TCAP, BGC) on ROE are the IDBs at the bottom-left of the chart — Marex is twice their ROE on similar scale. The two it cannot match on either margin or capital efficiency (IBKR, FLOW) sit at the extremes — IBKR has 10x the market cap and a different operating model, FLOW has a single-engine pure-principal book. SNEX is the awkward mid-cluster: better scale, lower ROE, but now bigger after RJO.
Where The Company Wins
Four advantages with hard evidence behind them — these are the moat sources, not management adjectives.
The most underrated of these is #2 — diversification under a rate-cut. The pre-IPO bear thesis was that rising NII flattered FY24 earnings and a cut cycle would expose the business. FY2025 ran the experiment: NII fell $74.5M and consolidated revenue grew $545M. No peer in the cohort has demonstrated the same offset in print, because no peer carries all four engines on one balance sheet.
Read the scorecard top-down: Marex tops cohort on ROE and revenue growth, mid-pack on margin (because comp ratio is 10pp higher than SNEX), and well below IBKR on every cost line because IBKR is electronic-only. The competitive question is whether Marex can drag the comp ratio down toward SNEX without giving up the high-touch coverage that explains its retention.
Where Competitors Are Better
Each peer beats Marex at something specific — soft spots an investor should worry about, not generic competitive language.
The deepest concession is to SNEX. Until July 2025 Marex was "the largest non-bank FCM in the US." It is not anymore. SNEX's RJO acquisition adds a 100+-year-old FCM, hundreds of introducing brokers, and a clearing float that pushes SNEX into a different scale class. RJO integration risk gives Marex a window — but if the integration sticks, the platform-broker premium narrative needs a new anchor.
Threat Map
Where the next 6-24 months of competitive pressure actually comes from. Severity is calibrated against the FY2025 P&L line that would absorb the impact.
The two High-severity threats both crystallised in one quarter (April-July 2025). That clustering is unusual — the FCM/IDB cohort had been static for years before — and is the single biggest reason the moat read tightened from "wide and widening" to "real but narrow" since Marex's 2024 IPO.
Moat Watchpoints
Measurable signals to track quarterly — competitive-position reads, distinct from the operating KPIs in the Business tab.
The single highest-signal watchpoint is #1. If Marex's average clearing client balances continue compounding faster than SNEX's combined client segregated and foreign secured funds (post-RJO), the platform thesis is intact and the FY2025 ROE premium is durable. If SNEX's balances grow faster — or if Marex balance growth stalls below industry FCM aggregate growth — the "best non-bank multi-asset broker" narrative is no longer earning its 13x P/E discount to SNEX's 27x. Everything else in the threat map is a refinement of that core question.